Biogenic Monoamines - Metabolism
Research News and Information

Saturday, November 21, 2009

Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model.

23 Jul 2009 To replicate the sleep-wake disorders of Parkinson's disease (PD) and to understand the temporal relationship between these sleep disturbances and the occurrence of parkinsonism, we performed long-term continuous electroencephalographic monitoring ... Read more...

Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.

31 May 2009 Caulis Sinomenii (QFT) has analgesic, sedative, and anxiolytic-like actions, and is proven effective for improving drug dependence that is known to be associated with abnormal monoaminergic transmission. We assessed whether QFT would be biologically ... Read more...

Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults.

30 May 2009 Social stress in adolescence is correlated with emergence of psychopathologies during early adulthood. In this study, the authors investigated the impact of social defeat stress during mid-adolescence on adult male brain and behavior. Adolescent ... Read more...

Latest indexed articles for 'Biogenic Monoamines - Metabolism'

These are the very latest articles for this heading:

• Mice with reduced vesicular monoamine storage content display nonmotor features of Parkinson's disease. 12 Oct 2009
• Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. 23 Jul 2009
• Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter. 31 May 2009
• Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults. 30 May 2009
• Trace amine-associated receptor 1 as a monoaminergic modulator in brain. 27 May 2009
• Impact of co administration of selenium and quinolinic acid in the rat's brain. 19 May 2009
• Effects of partial suppression of parkin on huntingtin mutant R6/1 mice. 19 May 2009
• X11-like protein deficiency is associated with impaired conflict resolution in mice. 4 May 2009
• Response disengagement on a spatial self-ordered sequencing task: effects of regionally selective excitotoxic lesions and serotonin depletion within the prefrontal cortex. 4 May 2009
• Consequences of sleep deprivation on neurotransmitter receptor expression and function. 29 Apr 2009
• Love and attachment: the psychobiology of social bonding. 29 Apr 2009
• Synthesis and monoamine uptake inhibition of conformationally constrained 2beta-carbomethoxy-3beta-phenyl tropanes. 27 Apr 2009
• Alternating vigilance states: new insights regarding neuronal networks and mechanisms. 26 Apr 2009
• Modulation of sickness behavior by sleep: the role of neurochemical and neuroinflammatory pathways in mice. 22 Apr 2009
• Safflower extracts functionally regulate monoamine transporters. 8 Apr 2009
• Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex. 7 Apr 2009
• Physical exercise and depression. 30 Mar 2009
• Parasite manipulation of brain monoamines in California killifish (Fundulus parvipinnis) by the trematode Euhaplorchis californiensis. 20 Mar 2009
• Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. 11 Mar 2009
• GPR3 receptor, a novel actor in the emotional-like responses. 2 Mar 2009

See a longer list of these articles.

Technical information about 'Biogenic Monoamines'

Definition: Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids.

Registry Number: 0

Descriptor UI: D015306

Alternative terms: Biogenic Monoamines; Monoamines, Biogenic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; biosynthesis; physiology;

Tree Number: D02.092.211.215;

History Note: 89

Technical Notes: general: prefer specifics